News
TRIB
2.920
-2.34%
-0.070
Weekly Report: what happened at TRIB last week (0715-0719)?
Weekly Report · 4d ago
Veterans Affairs Awards $4M Contract To Biopool US For Cost-Per-Test Services
Benzinga · 07/15 18:13
On July 12, 2024, Trinity Biotech Entered Into An ATM Offering Agreement With Craig-Hallum Capital Group, Pursuant To Which May Sell Up To $5.5M Of Its ADSs, Each ADS Representing 20 Of The Company's A Ordinary Shares (Co Will Also Pay Craig-Hallum A Commission Equal To 3% Of The Gross Sales Price Of ADSs)
Trinity Biotech plc entered into an At the Market Offering Agreement with Craig-Hallum Capital Group LLC on July 12, 2024. The Company may sell up to $5,500,000 of its American Depositary Shares. The company will pay Craig- hallum a commission equal to 3.0% of the gross sales price of the ADSs.
Benzinga · 07/15 15:21
Weekly Report: what happened at TRIB last week (0708-0712)?
Weekly Report · 07/15 09:26
Trinity Biotech Unveils New Share Offering Plan
TipRanks · 07/12 21:28
BRIEF-Trinity Biotech Says Entered Into An At Market Offering Agreement With Craig-Hallum Capital Group
Trinity Biotech Says Entered Into An At Market Offering Agreement With Craig-Hallum Capital Group. Company may sell up to $5.5 million of its American shares. Trinity Biotech says it has entered into the agreement with Craig- Hallum Capital group.
Reuters · 07/12 21:27
Executive reshuffles: ChargePoint, Tupperware and ADM in focus
Executive reshuffles: ChargePoint, Tupperware and ADM in focus. Several Wall Street executives stepped up for new roles as part of leadership reshuffling. Some companies such as ChargePoint and ADm added new positions to steer growth prospects to new positions.
Seeking Alpha · 07/12 16:15
Trinity Biotech Welcomes New CFO
TipRanks · 07/11 11:18
Trinity Biotech names Louise Tallon as CFO
Trinity Biotech plc names Louise Tallon as CFO. Tallon will join Trinity Biotech in August 2024. The company reiterated its financial guidance and intends to achieve $20M of annualized EBITDASO by Q2 2025. Trinity Biotechnology plc (TRIB) stock.
Seeking Alpha · 07/09 20:28
Trinity Biotech Announces Appointment Of Louise Tallon As Chief Financial Officer; Des Fitzgerald Will Continue As Interim CFO Until Late July 2024; Reiterates Financial Guidance And Intend To Achieve ~$20M Of Annualized Run-Rate EBITDASO On Annualized Revenues Of ~$75M By Q2 2025
Trinity Biotech plc appoints Louise Tallon as Chief Financial Officer. Tallon will join Trinity Biotech in August 2024. The company is focused on human diagnostics and diabetes management solutions and wearable biosensors. Des Fitzgerald will continue as interim CFO until late July 2024.
Benzinga · 07/09 20:07
TRINITY BIOTECH: REITERATE FINANCIAL GUIDANCE & INTEND TO ACHIEVE ABOUT $20 MLN OF ANNUALIZED RUN-RATE EBITDASOON ANNUALIZED REV OF ABOUT $75 MLN BY Q2 2025
Reuters · 07/09 20:05
Trinity Biotech Announces Appointment of A New CFO
Trinity Biotech plc appoints Louise Tallon as Chief Financial Officer. Louise will join Trinity Biotech in August 2024. The company is a commercial stage biotechnology company focused on human diagnostics and diabetes management. Des Fitzgerald will continue as interim CFO until late July 2024.
Barchart · 07/09 15:05
Weekly Report: what happened at TRIB last week (0701-0705)?
Weekly Report · 07/08 09:26
Weekly Report: what happened at TRIB last week (0624-0628)?
Weekly Report · 07/01 09:26
TRINITY BIOTECH PLC- RECEIVED REGULATORY APPROVAL TO CONDUCT ITS INITIAL EUROPEAN PRE-PIVOTAL TRIAL
Reuters · 06/24 11:05
TRINITY BIOTECH PLC: PRE-PIVOTAL TRIAL IS EXPECTED TO BE COMPLETED BY END OF JULY
Reuters · 06/24 11:05
Weekly Report: what happened at TRIB last week (0617-0621)?
Weekly Report · 06/24 09:27
Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor
Trinity Biotech plc announces steps to advance its next generation continuous glucose monitoring solution towards market launch. The company has received regulatory approval to conduct its initial European pre-pivotal trial. Trinity Biotech is focused on human diagnostics and diabetes management solutions.
Barchart · 06/24 06:00
Trinity Biotech files for $50M mixed shelf offering
Trinity Biotech files for $50M mixed shelf offering of up to $50 million. Trinity Biotech filed a prospectus related to a proposed mixed shelf sale. The company's stock is down 2.7% in the last week. The stock is a healthcare company.
Seeking Alpha · 06/21 20:39
BRIEF-Trinity Biotech Files For Mixed Shelf Offering Of Up To $50 Million- SEC Filing
Reuters · 06/21 20:18
More
Webull provides a variety of real-time TRIB stock news. You can receive the latest news about Trinity Biotech Plc through multiple platforms. This information may help you make smarter investment decisions.
About TRIB
Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic systems, including both reagents and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. It is a provider of raw materials to the life sciences and research industries globally. It also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ. The Company manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.